MEAN PLATELET VOLUME TO LYMPHOCYTE RATIO: A NOVEL MARKER FOR IDIOPATHIC SUDDEN SENSORINEURAL HEARING LOSS

Aim: To investigate the value of mean platelet volume (MPV) to lymphocyte ratio (MPVLR), a novel marker, in determining the prognosisof sudden sensorineural hearing loss (SSNHL).Materials and Methods: This retrospective cross-sectional study study included the patient group consisting of 65 SSNHL and thecontrol group consisting of 50 healthy individuals. 65 patients with SSNHL were divided into two subgroups as 44 recovered patients and21 unrecovered patients. The SSHNL patients and the control group, and the recovered SSNHL patients and the unrecovered SSNHLpatients were compared statistically in terms of MPV, lymphocyte count and MPVLR.Results: The mean MPV value was 9.28 ± 0.99 fL in the patients and 9.25 ±0.82 fL in the control group, and the difference was notstatistically significant (p = 0,851). The mean lymphocyte count was 1.90 ± 1.02 in the study group and 2.55± 0.78 in the control group,and the difference was statistically significant (p

Ortalama Trombosit Hacminin Lenfosit Sayısına Oranı: İdiopatik Ani Sensörinöral İşitme Kaybında Yeni Bir Belirteç

Amaç: Yeni bir marker olan MPVLR (Mean platelet volume to lymphocyte ratio) nin SSNHL (Ani sensörinöral işitme kaybı)’ nin prognozunda kullanılabilirliğini araştırmak. Materyal ve Metot: Bu retrospektif kesitsel çalışma 65 SSNHL li hasta ile 50 sağlıklı bireyden oluşan kontrol grubunu içermektedir. SSNHL li 65 hasta tedaviye cevap veren.44 hasta ile tedaviye cevap vermeyen 21 hasta olarak ikiye ayrılmıştır. SSNHL li hastalar ile kontrol grubu ve tedaviye cevap veren SSNHL’li hastalar ile tedaviye cevap vermeyen SSNHL li hastalar MPV (Mean platelet volume), lenfosit miktarı ve MPVLR açısından istatistiksel olarak karşılaştırılmıştır. Bulgular: Ortalama MPV değeri hastalarda 9.28 ± 0.99 fL iken çalışma grubunda 9.25 ±0.82 fL idi ve istatistiksel olarak farklı değildi (p = 0,851). Ortalama lenfosit miktarı çalışma grubunda 1.90 ± 1.02 iken kontrol grubunda 2.55± 0.78 idi ve istatistiksel olarak farklıydı (p

PDF

___

1. Alimoglu Y, Inci E, Edizer DT, Ozdilek A, Aslan M. Comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases. Eur Arch Otorhinolaryngol 2011(12);268:1735–41.

2. Prenzler NK, Schwab B, Kaplan DM , El-Saied S. The role of explorative tympanotomy in patients with sudden sensorineural hearing loss with and without perilymphatic fistula. Am J Otolaryngol. 2018(1); 39:46-9.

3. Durmuş K, Terzi H, Karatas TD, Doğan M, Uysal IÖ, Şencan M, et al. Assessment of Haematological factors involved in development and prognosis of idiopathic sudden sensorineural hearing loss, J. Craniofac Surg. 2016;27(1):85–91.

4. Bulgurcu S, Sahin B, Akgul G, Arslan İB, Çukurova İ. The Effects of Prognostic Factors in Idiopathic Sudden Hearing Loss. Int Arch Otorhinolaryngol. 2018;22(1):33-7.

5. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis, J Thromb Haemost 2010;8(1):148-56.

6. Hudzik B, Szkodziński J, Lekston A, Gierlotka M, Poloński L, Gąsior M. Mean platelet volume-to-lymphocyte ratio: a novel marker of poor short- and long-term prognosis in patients with diabetes mellitus and acute myocardial infarction. J Diabetes Complications. 2016; 30(6):1097-02.

7. Karli R, Alacam H, Unal R, Kucuk H, Aksoy A, Ayhan E et al. Mean platelet volume: is it a predictive parameter in the diagnosis of sudden sensorineural hearing loss? Indian J Otolaryngol Head Neck Surg. 2013;65(4):350-3.

8. Kocak HE, Elbistanlı MS, Acıpayam H, Alakras WME, Kıral MN, Kayhan FT. Are neutrophil/lymphocyte and platelet/lymphocyte ratios related with formation of sudden hearing loss and its prognosis? Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134(6):383-6.

9. Siegel LG. The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol. Clin N. Am. 1975; 8(2): 467-73.

10. Masuda M, Kanzaki S, Minami S, Kikuchi J, Kanzaki J, Sato H, et al. Correlations of inflammatory biomarkers with the onset and prognosis of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2012; 33(7):1142–50.

11. Almosnino G, Holm JR, Schwartz SR, Zeitler DM. The Role of Hyperbaric Oxygen as Salvage Therapy for Sudden Sensorineural Hearing Loss. Ann Otol Rhinol Laryngol. 2018; 127(10):672-6.

12. Mosnier I, Stepanian A, Baron G, Bodenez C, Robier A, Meyer B, et al. Cardiovascular and thromboembolic risk factors in idiopathic sudden sensorineural hearing loss: a case---control study. Audiol Neurootol. 2011; 16(1):55-66.

13. Mutlu A, Cam I, Dasli S, Topdag M. Doppler ultrasonography can be useful to determine the etiology of idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx. 2018; 45(3):456-60.

14. Kim JY, Hong JY, Kim DK. Association of Sudden Sensorineural Hearing Loss With Risk of Cardiocerebrovascular Disease: A Study Using Data From the Korea National Health Insurance Service. JAMA Otolaryngol Head Neck Surg. 2018;144(2):129-35.

15. Ullrich D, Aurbach G, Drobik C. A prospective study of hyperlipidemia as a pathogenic factor in sudden hearing loss. Eur Arch Otorhinolaryngol 1992; 249(5):273–6.

16. Ballesteros F, Alobid I, Tassies D, Reverter JC, Scharf RE, Guilemany JM, et al. Is there an overlap between sudden neurosensorial hearing loss and cardiovascular risk factors? Audiol Neurotol 2009;14(3):139–45.

17. Braekkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Størmer J, Hansen JB. Mean platelet volume is a risk factor for venous thromboembolism: the Tromso Study, Tromso, Norway. J Thromb Haemost 2010; 8(1):157-62.

18. Ulu S, Ulu MS, Ahsen A, Yucedag F, Aycicek A, Celik S. Increased levels of mean platelet volume: a possible relationship with idiopathic sudden hearing loss 2013; 270(11):2875-8

19. Kurtul A, Acikgoz SK. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2017; 120(4):534-41.

20. Bittencourt AG, Santos AF, Goffi-Gomez MV, Kutscher K, Tsuji RK, Brito RD et al .Microangiopathy of the inner ear, deafness, and cochlear implantation in a patient with Susac syndrome. Acta Otolaryngol. 2011;131(10):1123-28.

21. Lin RJ, Krall R, Westerberg BD, Chadha NK, Chau JK. Systematic review and meta-analysis of the risk factors for sudden sensorineural hearing loss in adults. Laryngoscope. 2012; 122(3):624-35.

22. Schulz S, Ritter J, Oertel K, Witt K, Bär KJ, Guntinas-Lichius O. Altered autonomic regulation as a cardiovascular risk marker for patients with sudden sensorineural hearing loss. Otol Neurotol. 2014;35(10):1720-9.

23. Le Tulzo Y, Pangault C, Gacouin A, Guilloux V, Tribut O, Amiot L et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 2002; 18(6):487-94.

24. Kassner SS, Schottler S, Bonaterra GA, Stern-Sträter J, Sommer U, Hormann K et al. Proinflammatory and proadhesive activation of lymphocytes and macrophages in sudden sensorineural hearing loss. Audiol Neurootol 2011; 16(4):254–62.